Clinical trial
Advanced Hepatocellular Carcinoma on Child B Cirrhosis: Tolerance and Efficacy of Torisel® (Temsirolimus)
NCT01079767 is registered in ClinicalTrials.gov with Federation Francophone de Cancerologie Digestive as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Advanced Hepatocellular Carcinoma on Child B Cirrhosis: Tolerance and Efficacy of Torisel® (Temsirolimus)
- Lead sponsor
- Federation Francophone de Cancerologie Digestive
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2010
- Completion date
- Not reported
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver cancer